Scholar Rock Holding (SRRK) Current Assets (2017 - 2026)
Scholar Rock Holding's quarterly Current Assets came in at $515.3 million in Q1 2026, up 33.75% year-on-year from $385.2 million in Q1 2025, and up 33.79% quarter-over-quarter from $385.1 million in Q4 2025.
Scholar Rock Holding has reported Current Assets for 10 years, with the latest figure at $515.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 33.75% year-over-year to $515.3 million; the trailing twelve-month figure through Mar 2026 stood at $515.3 million (up 33.75% YoY), and the FY2025 full-year result was $385.1 million, down 14.63% from the prior year.
- Current Assets for Q1 2026 stood at $515.3 million, up from $385.1 million in the prior quarter.
- The five-year high for Current Assets was $515.3 million in Q1 2026, with the low at $152.9 million in Q3 2024.
- Average Current Assets over 5 years is $318.4 million, with a median of $319.1 million recorded in 2025.
- Year-over-year, Current Assets sank 36.11% in 2023 and jumped 155.49% in 2025.
- Tracing SRRK's Current Assets over 5 years: stood at $328.0 million in 2022, then declined by 12.14% to $288.2 million in 2023, then surged by 56.55% to $451.2 million in 2024, then declined by 14.63% to $385.1 million in 2025, then surged by 33.79% to $515.3 million in 2026.
- The last three Current Assets figures came in at $515.3 million (Q1 2026), $385.1 million (Q4 2025), and $390.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 515.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 515.28 Mn |
| Dec 31, 2025 | 385.15 Mn |
| Sep 30, 2025 | 390.71 Mn |
| Jun 30, 2025 | 319.13 Mn |
| Mar 31, 2025 | 385.25 Mn |
| Dec 31, 2024 | 451.17 Mn |
| Sep 30, 2024 | 152.93 Mn |
| Jun 30, 2024 | 199.14 Mn |
| Mar 31, 2024 | 246.93 Mn |
| Dec 31, 2023 | 288.19 Mn |
| Sep 30, 2023 | 228.47 Mn |
| Jun 30, 2023 | 259.81 Mn |
| Mar 31, 2023 | 287.16 Mn |
| Dec 31, 2022 | 328.02 Mn |
| Sep 30, 2022 | 357.61 Mn |
| Jun 30, 2022 | 389.14 Mn |
| Mar 31, 2022 | 228.59 Mn |
| Dec 31, 2021 | 265.32 Mn |
| Sep 30, 2021 | 258.16 Mn |
| Jun 30, 2021 | 290.37 Mn |
| Mar 31, 2021 | 318.49 Mn |
| Dec 31, 2020 | 344.40 Mn |
| Sep 30, 2020 | 119.38 Mn |
| Jun 30, 2020 | 145.19 Mn |
| Mar 31, 2020 | 164.17 Mn |
| Dec 31, 2019 | 185.17 Mn |
| Sep 30, 2019 | 179.24 Mn |
| Jun 30, 2019 | 188.38 Mn |
| Mar 31, 2019 | 162.03 Mn |
| Dec 31, 2018 | 177.94 Mn |
| Sep 30, 2018 | 106.19 Mn |
| Jun 30, 2018 | 116.92 Mn |
| Dec 31, 2017 | 59.20 Mn |